The Biological Role and Therapeutic Potential of NK Cells in Hematological and Solid Tumors
NK cells are an attractive target for cancer immunotherapy due to their potent antitumor activity. The main advantage of using NK cells as cytotoxic effectors over T cells is a reduced risk of graft versus host disease. At present, several variants of NK-cell-based therapies are undergoing clinical...
Saved in:
Main Authors: | Rodion A. Velichinskii, Maria A. Streltsova, Sofya A. Kust, Alexander M. Sapozhnikov, Elena I. Kovalenko |
---|---|
Format: | article |
Language: | EN |
Published: |
MDPI AG
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/83ca3865322b4cc78ed811691b3cbe1c |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Race of CAR Therapies: CAR-NK Cells for Fighting B-Cell Hematological Cancers
by: Lara Herrera, et al.
Published: (2021) -
Cellular immunotherapy for hematological malignancy: recent progress and future perspectives
by: Zhengli Xu, et al.
Published: (2021) -
The Advantages and Challenges of Anticancer Dendritic Cell Vaccines and NK Cells in Adoptive Cell Immunotherapy
by: Elena V. Abakushina, et al.
Published: (2021) -
Current Perspectives on “Off-The-Shelf” Allogeneic NK and CAR-NK Cell Therapies
by: Erica L. Heipertz, et al.
Published: (2021) -
Horses for Courses in the Era of CARs: Advancing CAR T and CAR NK Cell Therapies
by: Sergey Kulemzin, et al.
Published: (2021)